OZEMPIC

Google image searchProduct monograph

Active ingredient

semaglutide, 0.68 MG/ML

DIN: 02540258

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: MULTIDOSE PREFILLED PEN DISPENSES 0.25MG OR 0.5MG DOSE

Schedule: Prescription / Schedule D

Company: NOVO NORDISK CANADA INC

Date: 22-DEC-2023

ATC:

• A10 — DRUGS USED IN DIABETES (ATC, ATC/DDD, )
• A10B — BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS (ATC, ATC/DDD)
• A10BJ — Glucagon-like peptide-1 (GLP-1) analogues (ATC, ATC/DDD)
• A10BJ06 — SEMAGLUTIDE (ATC/DDD)

Reference brand drug: Ozempic, Rybelsus, Wegovy

External Links for Ozempic

Search on Google

• Ozempic side effects
• Ozempic dosage
• semaglutide side effects
• semaglutide dosage

Novo Nordisk Canada Inc

Go to Novo Nordisk website to see drug product details. Sometimes you can find ozempic photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.